Although the U.S. Department of Justice's Antitrust Division would not confirm or deny that the investigation had been undertaken, Bristol-Myers disclosed the probe in its second-quarter earnings report on Thursday.

“The company learned yesterday that the Antitrust Division of the U.S. Department of Justice is conducting a criminal investigation regarding the proposed settlement of the Apotex...